Rettelse i tidsskrift

• Hege Fredriksen Berg; Marta Espevold Hjelmeland; Hilde Eide Lien et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (ekstern lenke)
• J. James E. Barrett; Chiara Herzog; Yoo-Na Kim et al. (2022). Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock (Genome Biology, (2022), 23, 1, (52), 10.1186/s13059-022-02603-3). (ekstern lenke)
• Eileen O. Dareng; Jonathan P. Tyrer; Daniel R. Barnes et al. (2022). Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362)). (ekstern lenke)
• Xia Jiang; Hilary K. Finucane; Fredrick Schumacher et al. (2019). Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4). (ekstern lenke)
• Åslaug Helland; Hege Elisabeth Giercksky Russnes; Gro Live Fagereng et al. (2022). Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway (Journal of Translational Medicine, (2022), 20, 1, (225), 10.1186/s12967-022-03432-5). (ekstern lenke)

Vitenskapelig artikkel

• Madalene Earp; Jonathan P. Tyrer; Stacey J. Winham et al. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. (ekstern lenke)
• James E. Barrett; Allison Jones; Iona Evans et al. (2022). The WID-EC test for the detection and risk prediction of endometrial cancer. (ekstern lenke)
• Delores J. Grant; Ani Manichaikul; Anthony J. Alberg et al. (2019). Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American women. (ekstern lenke)
• Hilde Renate Engerud; Hege Fredriksen Berg; Madeleine Myrvold et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (ekstern lenke)
• Xia Jiang; Hilary K. Finucane; Fredrick R. Schumacher et al. (2019). Shared heritability and functional enrichment across six solid cancers. (ekstern lenke)
• Line Bjørge; Heribert Stoiber; Manfred P. Dierich et al. (2006). Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy. (ekstern lenke)
• Johannes Landskron; Sigrid M. Kraggerud; Elisabeth Wik et al. (2017). C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease. (ekstern lenke)
• James E. Barrett; Chiara Herzog; Yoo-Na Kim et al. (2022). Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock. (ekstern lenke)
• Mansoor Raza Mirza; Troels K. Bergmann; Morten Mau-Sørensen et al. (2019). A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24. (ekstern lenke)
• Gabriel Cuellar-Partida; Yi Lu; Suzanne C. Dixon et al. (2016). Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. (ekstern lenke)
• Suzanne C. Dixon-Suen; Christina M Nagle; Aaron P. Thrift et al. (2018). Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study. (ekstern lenke)
• Eileen O. Dareng; Simon G. Coetzee; Jonathan P. Tyrer et al. (2024). Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions. (ekstern lenke)
• Catherine M. Phelan; Karoline B. Kuchenbaecker; Jonathan P. Tyrer et al. (2017). Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. (ekstern lenke)
• Jennifer B. Permuth; Brett Reid; Madalene Earp et al. (2016). Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: Results from a large-scale collaboration. (ekstern lenke)
• Katrin Kleinmanns; Stein-Erik Gullaksen; Geir Bredholt et al. (2022). Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies. (ekstern lenke)
• Linda Tømmerdal Roten; Liv Cecilie Vestrheim Thomsen; Astrid Gundersen et al. (2015). The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes. (ekstern lenke)
• Ann-Helen Kristoffersen; Per Hyltoft Petersen; Line Bjørge et al. (2019). Concentration of fibrin monomer in pregnancy and during the postpartum period. (ekstern lenke)
• Kate Lawrenson; Qiyuan Li; Siddhartha Kar et al. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. (ekstern lenke)
• Ana Oaknin; Laurence Gladieff; Jerónimo Martínez-García et al. (2023). Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial. (ekstern lenke)
• Jenny Hild Aase Husby; Øyvind Salvesen; Inger Johanne Magnussen et al. (2015). Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. (ekstern lenke)
• Mette Løkeland; Tone Bjørge; Ole-Erik Iversen et al. (2016). Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013. (ekstern lenke)
• Marie Austdal; Liv Cecilie Vestrheim Thomsen; Line Haugstad Tangerås et al. (2015). Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. (ekstern lenke)
• Tormund Salvesen Njølstad; Henrica Maria Johanna Werner; Janusz Marcickiewicz et al. (2017). Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study. (ekstern lenke)
• Mona Høysæter Fenstad; Matthew Johnson; Mari Løset et al. (2010). STOX2 but not STOX1 is differently expressed in preeclampstic decidua from Norwegian women: data from the Second Nord-Trondelag Health Study. (ekstern lenke)
• Kate Lawrenson; Siddhartha Kar; Karen McCue et al. (2016). Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. (ekstern lenke)
• Ingvild Vistad; Line Bjørge; Olesya Popova et al. (2017). A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway. (ekstern lenke)
• Hege Fredriksen Berg; Marta Espevold Hjelmeland; Hilde Eide Lien et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (ekstern lenke)
• Anna Berg; Kristine Eldevik Fasmer; Karen Klepsland Mauland et al. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. (ekstern lenke)
• Dylan M. Glubb; Sharon E. Johnatty; Michael C.J. Quinn et al. (2017). Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. (ekstern lenke)
• Christiane Helgestad Gjerde; Katrin Kleinmanns; Anika Langer et al. (2026). A 3D ovarian cancer metastasis model using a decellularised peritoneal matrix to study therapy response. (ekstern lenke)
• Andreas du Bois; Gunnar S Balle Kristensen; Isabelle Ray-Coquard et al. (2016). Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): A randomised, double-blind, placebo-controlled phase 3 trial. (ekstern lenke)
• Ann-Helen Kristoffersen; Per Hyltoft Petersen; Line Bjørge et al. (2018). Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women. (ekstern lenke)
• Nuno R. Nené; James Barrett; Allison Jones et al. (2020). DNA methylation signatures to predict the cervicovaginal microbiome status. (ekstern lenke)
• Torkel Harboe; Michael D. Benson; Hanaku Oi et al. (2006). Cardiopulmonary distress during obstetrical anaesthesia: attempts to diagnose amniotic fluid embolism in a case series of suspected allergic anaphylaxis. (ekstern lenke)
• Ingfrid S. Haldorsen; Ingunn Stefansson; Renate Grüner et al. (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. (ekstern lenke)
• Bente Vilming; Jørgen Fallås Dahl; Anne Gry Bentzen et al. (2023). Real-world data on niraparib maintenance treatment in patients with non-gBRCA mutated platinum-sensitive recurrent ovarian cancer. (ekstern lenke)
• Ferenc Macsali; Francisco Gomez Real; Ernst Omenaas et al. (2009). Oral contraception, body mass index, and asthma: A cross-sectional Nordic-Baltic population survey. (ekstern lenke)
• Øystein Helland; Mihaela Lucia Popa; Katharina Bischof et al. (2016). The HDACi panobinostat shows growth inhibition both in vitro and in a bioluminescent orthotopic surgical xenograft model of ovarian cancer. (ekstern lenke)
• Karen Klepsland Mauland; Zhenlin Ju; Ingvild Løberg Tangen et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (ekstern lenke)
• Tarjei Sveinsgjerd Hveem; Tormund Salvesen Njølstad; Birgitte Nielsen et al. (2016). Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer. (ekstern lenke)
• Mansoor Raza Mirza; Elisabeth Åvall Lundqvist; Michael J. Birrer et al. (2019). Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial. (ekstern lenke)
• Ingfrid S. Haldorsen; Renate Grüner; Jenny Hild Aase Husby et al. (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. (ekstern lenke)
• Shamundeeswari Anandan; Liv Cecilie Vestrheim Thomsen; Stein-Erik Gullaksen et al. (2021). Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods. (ekstern lenke)
• Anna Berg; Ankush Gulati; Sigmund Ytre-Hauge et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Philip E. Melton; Kjersti Tollaksen et al. (2015). Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. (ekstern lenke)
• Nicholas Paul Casey; Katrin Kleinmanns; Christopher Forcados et al. (2024). Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16. (ekstern lenke)
• Ole Jacob Møllerløkken; Bente Elisabeth Moen; Valborg Baste et al. (2012). No effects of MRI scan on male reproduction hormones. (ekstern lenke)
• Hanne Marie Haugan; Line Bjørge; Mette Løkeland-Stai (2023). Nemndabort 1979–2022 – hva har skjedd?. (ekstern lenke)
• Katrin Kleinmanns; Vibeke Samuelsen Fosse; Ben Davidson et al. (2020). CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model. (ekstern lenke)
• Ingvild Løberg Tangen; Reidun Kristin Kopperud; Nicole C.M. Visser et al. (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. (ekstern lenke)
• Katharina Bischof; Stian Knappskog; Ingunn Stefansson et al. (2018). High expression of the p53 isoform ? is associated with reduced progression-free survival in uterine serous carcinoma. (ekstern lenke)
• Einar Klæboe Kristoffersen; Kjell Haram; Britt Edvardsen et al. (2006). Placental expression of glycophosphatidylinositol (GPI)-anchored proteins in paroxysmal nocturnal haemoglobinuria. (ekstern lenke)
• Johannes Landskron; Øystein Helland; Knut Martin Torgersen et al. (2014). Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. (ekstern lenke)
• Åsa Johansson; Joanne E Curran; Matthew p. Johnson et al. (2011). Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. (ekstern lenke)
• Melissa C Southey; David E Goldgar; Robert Winqvist et al. (2016). PALB2, CHEK2 and ATM rare variants and cancer risk: Data from COGS. (ekstern lenke)
• Chiara Herzog; Fátima Marín; Allison Jones et al. (2022). A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets. (ekstern lenke)
• Suzanne C. Dixon; Christina M Nagle; AG Thrift et al. (2016). Adult body-mass index and ovarian cancer risk by subtype: A Mendelian randomization study. (ekstern lenke)
• Elvira García de Jalón; Katrin Kleinmanns; Vibeke Samuelsen Fosse et al. (2021). Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model. (ekstern lenke)
• Alejandro Perez-Fidalgo; Barbara Schmalfeldt; Angela George et al. (2024). Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer. (ekstern lenke)
• Johanne Johnsen Rakner; Gabriela Silva; Siv Boon Mundal et al. (2021). Decidual and placental NOD1 is associated with inflammation in normal and preeclamptic pregnancies. (ekstern lenke)
• Katrin Kleinmanns; Katharina Bischof; Shamundeeswari Anandan et al. (2020). CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma. (ekstern lenke)
• Karen Gissum; Sigrunn Drageset; Liv Cecilie Vestrheim Thomsen et al. (2024). Navigating the Complexities of Ovarian Cancer Care: Perspectives from Nurses. (ekstern lenke)
• Nuno R. Nené; Daniel Reisel; Andreas Leimbach et al. (2019). Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. (ekstern lenke)
• Maj K. Kjeldsen; Morten Jørgensen; Dina Sofie B Grønseth et al. (2024). Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer. (ekstern lenke)
• Eileen O. Dareng; Jonathan P. Tyrer; Daniel R. Barnes et al. (2022). Polygenic risk modeling for prediction of epithelial ovarian cancer risk. (ekstern lenke)
• Line Haugstad Tangerås; Gabriela Silva; Guro Stødle et al. (2018). Placental inflammation by HMGB1 activation of TLR4 at the syncytium. (ekstern lenke)
• Jue-Sheng Ong; Gabriel Cuellar-Partida; Yi Lu et al. (2016). Association of vitamin D levels and risk of ovarian cancer: A Mendelian randomization study. (ekstern lenke)
• Cecilie Fredvik Torkildsen; Liv Cecilie Vestrheim Thomsen; Ragnar Sande et al. (2023). Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. (ekstern lenke)
• Siddhartha P. Kar; Jonathan P. Tyrer; Qiyuan Li et al. (2015). Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. (ekstern lenke)
• Magdalene A Earp; Linda E. Kelemen; Anthony M. Magliocco et al. (2014). Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. (ekstern lenke)
• Katharina Bischof; Andrea Cremaschi; Lena Eroukhmanoff et al. (2024). Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Linda Tømmerdal Roten; Kari Klungsøyr et al. (2013). Validity of pre-eclampsia diagnosis in Medical Birth Registry of Norway. (ekstern lenke)
• Grete Alræk Iversen; Mette Løkeland; Anneli Kathrine Fjereide et al. (2012). Er det mulig å få pålitelig kunnskap om psykiske senvirkninger etter provosert abort?. (ekstern lenke)
• Cecilie Fredvik Torkildsen; Marie Austdal; Anders Hagen Jarmund et al. (2024). New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients. (ekstern lenke)
• Harsh Dongre; Neha Rana; Siren Fromreide et al. (2020). Establishment of a novel cancer cell line derived from vulvar carcinoma associated with lichen sclerosus exhibiting a fibroblast-dependent tumorigenic potential. (ekstern lenke)
• Tone Bjørge; Gry Baadstrand Skare; Line Bjørge et al. (2016). Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia. (ekstern lenke)
• Kristine Eldevik Fasmer; Atle Bjørnerud; Sigmund Ytre-Hauge et al. (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. (ekstern lenke)
• James E. Barrett; Allison Jones; Iona Evans et al. (2022). The DNA methylome of cervical cells can predict the presence of ovarian cancer. (ekstern lenke)
• Dylan M. Glubb; Deborah J. Thompson; Katja K H Aben et al. (2021). Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers. (ekstern lenke)
• Karoline B. Kuchenbäcker; Susan J. Ramus; Jonathan Tyrer et al. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. (ekstern lenke)
• Tone Bjørge; Vidar Hjellvik; Line Bjørge et al. (2023). Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study. (ekstern lenke)
• Tina Fonnes; Jone Trovik; Per-Henrik D. Edqvist et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (ekstern lenke)
• Katarina Puco; Gro Live Fagereng; Sigmund Brabrand et al. (2024). IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results. (ekstern lenke)
• Ingvild Vistad; Mette Skorstad; Sveinung Berntsen et al. (2025). Empowerment and quality of life in gynecological cancer survivors: Outcomes from a multicenter quasi-experimental cohort study from Norway (the LETSGO trial). (ekstern lenke)
• Yingchang Lu; Alicia Beeghly-Fadiel; Lang Wu et al. (2018). A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk. (ekstern lenke)
• Per Eystein Lønning; Elisabet Ognedal Berge; Merete Pauline Bjørnslett et al. (2018). White blood cell BRCA1 promoter methylation status and ovarian cancer risk. (ekstern lenke)
• Luka Tandaric; Line Bjørge; Martine Rott Lode et al. (2026). Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy. (ekstern lenke)
• Chiara M.S. Herzog; Bente Theeuwes; Allison Jones et al. (2025). Systems epigenetic approach towards non-invasive breast cancer detection. (ekstern lenke)
• Kenneth Sooi; Tuan Zea Tan; Jae Weon Kim et al. (2025). A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients. (ekstern lenke)
• Daniel R. Barnes; Jonathan P. Tyrer; Joe Dennis et al. (2025). Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer. (ekstern lenke)
• Michael C.J. Quinn; Karen McCue; Wei Shi et al. (2021). Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer. (ekstern lenke)
• Sigmund Ytre-Hauge; Jenny Hild Aase Husby; Inger Johanne Magnussen et al. (2015). Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. (ekstern lenke)
• Linda E. Kelemen; Kate Lawrenson; Jonathan Tyrer et al. (2015). Genome-wide significant risk associations for mucinous ovarian carcinoma. (ekstern lenke)
• Luka Tandaric; Annika Auranen; Katrin Kleinmanns et al. (2025). Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in arm A of the NSGO-OV-UMB1/ENGOT-OV30 trial. (ekstern lenke)
• Alice W. Lee; Jonathan P Tyrer; Jennifer A Doherty et al. (2015). Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study. (ekstern lenke)
• Ingrid Alsos Lian; Mari Løset; Siv Boon Mundal et al. (2011). Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia. (ekstern lenke)
• Kate Lawrenson; Edwin S. Iversen; Jonathan Tyrer et al. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. (ekstern lenke)
• Maria Grazia Perrone; Paola Vitale; Morena Miciaccia et al. (2022). Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes. (ekstern lenke)
• Øystein Helland; Mihaela Lucia Popa; Olav Karsten Vintermyr et al. (2014). First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma. (ekstern lenke)
• Ferenc Macsali; Cecilie Svanes; R. B. Sothern et al. (2013). Menstrual Cycle and Respiratory Symptoms in a General Nordic-Baltic Population. (ekstern lenke)
• Linda E. Kelemen; Madalene Earp; Brooke L. Fridley et al. (2018). rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology. (ekstern lenke)
• Dong Liang; Michelle A T Hildebrant; Roberta B Ness et al. (2016). BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (ekstern lenke)
• Mansoor R. Mirza; Line Bjørge; Frederik Marmé et al. (2025). Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial. (ekstern lenke)
• Taymaa May; Marcus Bernardini; Stephanie Lheureux et al. (2023). Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis. (ekstern lenke)
• Johannes Landskron; Øystein Helland; Knut Martin Torgersen et al. (2015). Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. (ekstern lenke)
• Mette Løkeland; Ole-Erik Iversen; Anders Engeland et al. (2014). Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation. (ekstern lenke)
• Harsh Nitin Dongre; Rammah Elnour; Stian Tornaas et al. (2023). TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma. (ekstern lenke)
• Ingrid Alsos Lian; Johanne Holm Toft; Guro Dalheim Olsen et al. (2010). Matrix Metalloproteinase 1 in Pre-eclampsia and Fetal Growth Restriction: Reduced Gene Expression in Decidual Tissue and Protein Expression in Extravillous Trophoblasts. (ekstern lenke)
• Ernest K. Amankwah; Hui-Yi Lin; Jonathan P. Tyrer et al. (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Katrin Kleinmanns; Shamundeeswari Anandan et al. (2023). Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study. (ekstern lenke)
• Sigmund Ytre-Hauge; Morteza Esmaeili; Torill Eidhammer Sjøbakk et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (ekstern lenke)
• Karen Rosnes Gissum; Sigrunn Drageset; Liv Cecilie Vestrheim Thomsen et al. (2022). Living With Ovarian Cancer: Transitions Lost in Translation. (ekstern lenke)
• James E. Barrett; Chiara Herzog; Allison Jones et al. (2022). The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples. (ekstern lenke)
• Gabriela Silva; Lobke Gierman; Johanne Johnsen Rakner et al. (2020). Cholesterol crystals and NLRP3 mediated inflammation in the uterine wall decidua in normal and preeclamptic pregnancies. (ekstern lenke)
• Mari Løset; Siv Boon Mundal; Matthew Johnson et al. (2011). A transcriptional profile of the decidua in preeclampsia. (ekstern lenke)
• Mette Løkeland; Ole-Erik Iversen; Gunhild Svanes Dahle et al. (2010). Medical Abortion at 63 to 90 Days of Gestation. (ekstern lenke)
• Sigmund Ytre-Hauge; Julie Andrea Dybvik; Arvid Lundervold et al. (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. (ekstern lenke)
• Rammah Elnour; Ingjerd Helstrup Hindenes; Malene Færevaag et al. (2025). Prognostic Value of an Integrated Human Papillomavirus and Immunoscore Model to Predict Survival in Vulva Squamous Cell Carcinoma. (ekstern lenke)
• Ingunn Dybedal; Nina Iversen; Anne Flem Jacobsen et al. (2025). Hereditary antithrombin deficiency and venous thrombosis in pregnancy–results of a retrospective multicenter study. (ekstern lenke)
• Rafaela Abrantes; Christopher Forcados; David Warren et al. (2025). Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors. (ekstern lenke)
• Line Bjørge; Heribert Stoiber; Seppo Meri (2006). Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy. (ekstern lenke)
• Shalaka S. Hampras; Lara E. Sucheston-Campbell; Rikki Cannioto et al. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. (ekstern lenke)
• Siv Boon Mundal; Johanne Johnsen Rakner; Gabriela Silva et al. (2022). Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Kari Klungsøyr Melve; Linda Tømmerdal Roten et al. (2013). Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway. (ekstern lenke)
• William J. Gibson; Erling Andre Høivik; Mari Kyllesø Halle et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (ekstern lenke)
• Tina Fonnes; Elin Strand; Kristine Eldevik Fasmer et al. (2020). Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Nina McCarthy; Philip E. Melton et al. (2016). The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia. (ekstern lenke)
• Katharina Bischof; Stian Knappskog; Sigrun Margrethe Hjelle et al. (2019). Influence of p53 isoform expression on survival in high-grade serous ovarian cancers. (ekstern lenke)
• Valborg Baste; Bente Elisabeth Moen; Gunnhild Oftedal et al. (2012). Pregnancy outcomes after paternal radiofrequency field exposure aboard fast patrol boats. (ekstern lenke)
• Ganna Chornokur; Hui-Yi Lin; Jonathan P. Tyrer et al. (2015). Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. (ekstern lenke)
• Yi Lu; Gabriel Cuellar-Partida; Jodie N. Painter et al. (2015). Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. (ekstern lenke)
• Guro Stødle; Gabriela Silva; Line Haugstad Tangerås et al. (2018). Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. (ekstern lenke)
• Christoph Wohlmuth; Vladimir Djedovic; Susanne K. Kjær et al. (2022). CA-125 levels are predictive of survival in low-grade serous ovarian cancer—A multicenter analysis. (ekstern lenke)
• Akinyemi Ojesina; Lee Lichtenstein; Samuel S. Freeman et al. (2014). Landscape of genomic alterations in cervical carcinomas. (ekstern lenke)
• Cecilie Fredvik Torkildsen; Marie Austdal; Ann-Charlotte Iversen et al. (2023). Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins. (ekstern lenke)
• Karen Madland; Line Bjørge; Milada Cvancarova Småstuen et al. (2022). Symptomatic or asymptomatic recurrence of ovarian cancer: does it influence survival?. (ekstern lenke)
• Yaohua Yang; Lang Wu; Xiang Shu et al. (2019). Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. (ekstern lenke)
• Eirik Tveit Solheim; Liv Cecilie Vestrheim Thomsen; Line Bjørge et al. (2024). Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration. (ekstern lenke)
• Isabelle Ray-Coquard; David Cibula; Mansoor R. Mirza et al. (2019). Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer. (ekstern lenke)
• M.R. Mirza; Luka Tandaric; J.R. Henriksen et al. (2024). NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer. (ekstern lenke)
• M.A. Powell; Line Bjørge; L. Willmott et al. (2024). Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial. (ekstern lenke)
• Linda E. Kelemen; Kathryn L. Terry; Marc T. Goodman et al. (2014). Consortium analysis of diet-gene interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.. (ekstern lenke)
• Dhanya Ramachandran; Jonathan P. Tyrer; Stefan Kommoss et al. (2024). Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease. (ekstern lenke)
• Line Bjørge; Jaakku Hakulinen; Olav Karsten Vintermyr et al. (2005). Ascitic complement system in ovarian cancer. (ekstern lenke)
• Jenny Hild Aase Husby; Bernt Christian Reitan; Martin Biermann et al. (2015). Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. (ekstern lenke)
• Johanne Holm Toft; Ingrid Alsos Lian; AL Tarca et al. (2008). Whole-genome microarray and targeted placental analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PIGF) from pre-eclamptic and small-for-gegstational-age pregnancies. (ekstern lenke)
• Marie Austdal; Gabriela Silva; Sophie Bowe et al. (2019). Metabolomics identifies placental dysfunction and confirms Flt-1 (FMS-like tyrosine kinase receptor 1) biomarker specificity. (ekstern lenke)

Konferanseforedrag

• Ann-Charlotte Iversen; Line Bjørge (2013). Preeclampsia and cardiovascular disease - shared causative genetic mechanisms?. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Philip E. Melton; Chen Sun et al. (2013). Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. (ekstern lenke)
• Christiane Helgestad Gjerde; Anika Langer; Gorka Ruiz de Garibay et al. (2022). Establishment of peritoneal dECM scaffolds for culture of ovarian cancer organoids. (ekstern lenke)
• Johanne Johnsen Rakner; Gabriela Silva; Mattijs Elschot et al. (2021). The link between inflammatory and vascular pathology and sFlt-1 expression at the maternal-fetal interface in preeclampsia. (ekstern lenke)
• Ingrid Alsos Lian; Mari Løset; Siv Boon Mundal et al. (2010). Endoplasmic reticulum stress in decidual tissue from pregnancies complicated by pre-eclampsia. (ekstern lenke)
• Siv Boon Mundal; Gabriela Silva; Guro Stødle et al. (2018). Decidual inflammation in normal and preeclamptic pregnancies. (ekstern lenke)
• Christiane Helgestad Gjerde; Anika Langer; Gorka Ruiz de Garibay et al. (2022). Establishment of ovarian cancer organoids on peritoneal dECM scaffolds. (ekstern lenke)
• Karen Rosnes Gissum; Line Bjørge; Roger Strand (2021). Between Illness and Disease: Ovarian Cancer Lost in Translation. (ekstern lenke)
• Mette Løkeland; Ole-Erik Iversen; Line Bjørge (2011). MEDICAL ABORTION WITH HOME ADMINISTRATION OF MISOPROSTOL UP TO 63 DAYS GESTATION. (ekstern lenke)
• Mette Løkeland; Line Bjørge (2008). Women's choices: Why do they opt for medical abortion?. (ekstern lenke)
• Anders Hagen Jarmund; Guro F. Giskeødegård; Johanne Johnsen Rakner et al. (2021). Systemic immunological perturbations and placental pathology in preeclampsia. (ekstern lenke)
• Mette Løkeland; Line Bjørge (2010). Norway: In transition from surgical to medical termination. (ekstern lenke)
• Anders Hagen Jarmund; Guro F. Giskeødegård; Mariell Ryssdal et al. (2023). Decoding the immune and lipid landscape of preeclampsia: A study of disease subtypes and activity. (ekstern lenke)
• Siv Boon Mundal; Purusotam Basnet; Gabriela Silva et al. (2016). Decidual Nrf2-mediated oxidative stress response in preeclampsia and fetal growth restriction. (ekstern lenke)
• Gabriela Silva; Line Haugstad Tangerås; Guro Stødle et al. (2015). The inflammatory role of HMGB1 in preeclampsia. (ekstern lenke)
• Anders Hagen Jarmund; Åse Turid Rossevatn Svoren; Johanne Johnsen Rakner et al. (2025). Distinkte sykdomsprosesser i placenta, decidua og serum hos mor ved preeklampsi med og uten føtal veksthemming. (ekstern lenke)
• Linda Tømmerdal Roten; Matthew Johnson; Liv Cecilie Vestrheim Thomsen et al. (2013). A preeclampsia genome-wide linkage scan in Norwegian families. (ekstern lenke)
• Christiane Helgestad Gjerde; Gorka Ruiz de Garibay; Emmet Matin Mccormack et al. (2020). Rethinking ovarian cancer: Establishment of an organoid-based preclinical platform for ovarian cancer.. (ekstern lenke)
• Johanne Johnsen Rakner; Gabriela Silva; Mattijs Elschot et al. (2021). The link between sFlt-1 expression and inflammatory and vascular pathology at the maternal-fetal interface in preeclampsia. (ekstern lenke)
• Karen Rosnes Gissum; Line Bjørge (2019). What you should know about tumor reductive surgery in advanced ovarian cancer – Clinical recommendations from a patient perspective. (ekstern lenke)

Fagartikkel

• Anne Flem Jacobsen; Annette Kristiansen; Line Bjørge et al. (2014). Antikoagulasjon ved venøs trombose i svangerskapet. (ekstern lenke)
• Åslaug Helland; Hege Elisabeth Giercksky Russnes; Gro Live Fagereng et al. (2022). Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway. (ekstern lenke)
• Katrin Kleinmanns; Line Bjørge (2024). Prospects for precision medicine in ovarian cancer.. (ekstern lenke)
• Line Bjørge (2024). Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup. (ekstern lenke)

Konferanseabstrakt

• Øystein Helland; Mihaela Lucia Popa; Olav Karsten Vintermyr et al. (2012). Establishment of a bioluminescence orthotopic mouse model of ovarian carcinoma: Analysis of tumor growth and response to therapy. (ekstern lenke)
• Anders Hagen Jarmund; Åse Turid Rossevatn Svoren; Signe Haaland Buer et al. (2023). Dyslipidemia and immunological deviation in diagnosed preeclampsia. (ekstern lenke)
• Gabriela Silva; Guro Stødle; Lobke Gierman et al. (2018). Decidual inflammation in normal and preeclamptic pregnancies. (ekstern lenke)
• Guro Stødle; Gabriela Silva; Line Haugstad Tangerås et al. (2017). Inflammation in preeclampsia by NOD-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. (ekstern lenke)
• Lobke Gierman; Zahra Pervaiz; Gabriela Silva et al. (2017). An inflammatory role for TLR3 in decidua and placenta of normal and preeclamptic pregnancies. (ekstern lenke)
• Øystein Helland; P. Mihaela; Bjørn Tore Gjertsen et al. (2013). PANOBINOSTAT / CARBOPLATIN DELAY POSTSURGICAL RELAPSE OF OVARIAN CARCINOMA IN AN ORTHOTOPIC MOUSE MODEL. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Nina McCarthy; Philip E. Melton et al. (2015). Identifying a novel link between preeclampsia and chronic hypertension in the MTHFR gene using the population based Norwegian HUNT Study. (ekstern lenke)
• Pervaiz Zahra; Lobke Gierman; Gabriela Brettas Silva et al. (2019). Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy. (ekstern lenke)
• Ingrid Alsos Lian; Mari Løset; Siv Boon Mundal et al. (2011). Endoplasmic reticulum stress in decidual tissue from pregnancies complicated by pre-eclampsia and fetal growth restriction. (ekstern lenke)
• Cecilie Fredvik Torkildsen; Kristina Yvonne Kathe Lindemann; Katharina Bischof et al. (2024). 456 Molecular characteristics of gynaecological cancer patients in the IMPRESS-Norway trial – a national prospective, non-randomized clinical trial evaluating the efficacy of anti-cancer drugs on new indications. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Nina McCarthy; Philip E. Melton et al. (2015). A genetic connection between preeclampsia and chronic hypertension in Norwegian families. (ekstern lenke)
• Mette Løkeland; Ole-Erik Iversen; Line Bjørge (2012). Medical abortion at 9-12 weeks. (ekstern lenke)
• Anders Hagen Jarmund; Guro F. Giskeødegård; Johanne Johnsen Rakner et al. (2021). Systemic immunological perturbations and placental pathology in preeclampsia. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Ann-Charlotte Iversen; Linda Tømmerdal Roten et al. (2012). INVESTIGATING GENETIC PREDISPOSITION AND CLINICAL OCCURRENCE OF PREECLAMPSIA AND CARDIOVASCULAR DISEASE THROUGH A FAMILY-BASED DESIGN. (ekstern lenke)
• Ingvild Vistad; Mette Skorstad; Milada Hagen et al. (2025). The Impact Of The LETSGO Personalized Follow-Up Model On Empowerment And Quality Of Life In Gynaecological Cancer Survivors: A Multicenter Quasi-Experimental Study. (ekstern lenke)
• Anders Hagen Jarmund; Johanne Johnsen Rakner; Åse Turid Rossevatn Svoren et al. (2025). sFlt-1 expression at the maternal-fetal interface and in maternal serum is not coregulated and show divergent upregulation in preeclampsia subtypes. (ekstern lenke)
• Linda Tømmerdal Roten; Matthew Johnson; Liv Cecilie Vestrheim Thomsen et al. (2013). A preeclampsia genome-wide linkage scan in Norwegian families. (ekstern lenke)
• Lobke Gierman; Gabriela Brettas Silva; Pervaiz Zahra et al. (2019). Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia. (ekstern lenke)
• Lara E. Sucheston-Campbell; Rikki Cannioto; Alyssa I. Clay et al. (2017). No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. (ekstern lenke)
• Line Haugstad Tangerås; Guro Stødle; Gabriela Silva et al. (2015). The inflammatory role of HMGB1 in preeclampsia. (ekstern lenke)
• Ingrid Alsos Lian; Mari Løset; Siv Boon Mundal et al. (2010). Endoplasmatic reticulum stress in decidual tissue from pregnancies complicated with preeclampsia. (ekstern lenke)
• Lobke Gierman; Guro Stødle; Gabriela Silva et al. (2016). NLRP3 inflammasome expression and activation at the maternal-fetal interface in preeclamptic and healthy pregnancies. (ekstern lenke)
• Signe Haaland Buer; Anders Hagen Jarmund; Åse Turid Rossevatn Svoren et al. (2023). Distinct immunological development throughout pregnancies complicated with preeclampsia, gestational hypertension, and chronic hypertension. (ekstern lenke)
• Johanne Johnsen Rakner; Lobke Gierman; Gabriela Silva et al. (2017). An inflammatory role for NOD1 in decidua and placenta of normal and preeclamptic pregnancies. (ekstern lenke)
• Siv Boon Mundal; Gabriela Brettas Silva; Lobke Gierman et al. (2019). Divergent regulation of decidual oxidative stress response in preeclampsia with and without fetal growth restriction. (ekstern lenke)
• Liv Cecilie Vestrheim; Rigmor Austgulen; Kari Klungsøyr Melve et al. (2010). Classification of pre-eclamptic pregnancies in health registries. An evaluation of criteria selected and pregnancies included in the Medical Birth Registry of Norway. (ekstern lenke)
• Anders Hagen Jarmund; Åse Turid Rossevatn Svoren; Johanne Johnsen Rakner et al. (2025). Distinkte sykdomsprosesser i placenta, decidua og serum hos mor ved preeklampsi med og uten føtal veksthemming. (ekstern lenke)
• Gabriela Brettas Silva; Lobke Gierman; Guro Stødle et al. (2019). The NLRP3 inflammasome expression by maternal and fetal cells in the uterine wall and association with preeclampsia development.. (ekstern lenke)
• Linda Tømmerdal Roten; Liv Cecilie Vestrheim Thomsen; Astrid Gundersen et al. (2011). Establishment of a Norwegian Preeclampsia Family Biobank. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Ann-Charlotte Iversen; Ingvill Lyslo et al. (2012). A population and family based study design to investigate genetic predisposition to preeclampsia and cardiovascular disease. The Norwegian Preeclampsia Family Study. (ekstern lenke)
• Johanne Johnsen Rakner; Gabriela Silva; Mattijs Elschot et al. (2021). The link between inflammatory and vascular pathology and sFlt-1 expression at the maternal-fetal interface in preeclampsia. (ekstern lenke)
• Mette Løkeland; Ole-Erik Iversen; Stein Emil Vollset et al. (2012). Trender i bruken av medikamentell abort i Noreg. (ekstern lenke)
• Birgitte Nordby; Marthe Rosvoll; Ole-Erik Iversen et al. (2012). HPV-vaksinasjon – er kunnskapsnivået hos norske medisinetstudenter og allmennleger tilstrekkelig høyt?. (ekstern lenke)
• Anne Flem Jacobsen; Tore Henriksen; Line Bjørge et al. (2012). Venøs trombose i svangerskapet: Internasjonale retningslinjer blir norske. (ekstern lenke)
• Johanne Johnsen Rakner; Gabriela Silva; Mattijs Elschot et al. (2021). The link between sFlt-1 expression and inflammatory and vascular pathology at the maternal-fetal interface in preeclampsia. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Philip E. Melton; Chen Sun et al. (2013). Arvelighet av kardiovaskulær sykdom i en familiekohort med økt forekomst av preeklampsi. (ekstern lenke)
• Marie Austdal; Gabriela Brettas Silva; Sophie Bowe et al. (2019). Metabolomics identifies placental dysfunction and confirms Flt-1 biomarker specificity.. (ekstern lenke)
• Mette Løkeland; Ole-Erik Iversen; Line Bjørge (2012). Medical abortion with home administration of misoprostol up to 63 days gestation. (ekstern lenke)

Konferanseposter

• Siv Boon Mundal; Purusotam Basnet; Gabriela Silva et al. (2016). Nrf2-mediated oxidative stress response at the maternal-fetal interface in preeclampsia and fetal growth restriction. (ekstern lenke)
• Lobke Gierman; Zahra Pervaiz; Gabriela Silva et al. (2017). An inflammatory role for TLR3 in decidua and placenta of normal and preeclamptic pregnancies. (ekstern lenke)
• Anders Hagen Jarmund; Åse Turid Rossevatn Svoren; Signe Haaland Buer et al. (2023). Immune deviation and dyslipidemia in diagnosed preeclampsia. (ekstern lenke)
• Øystein Helland; Katharina Bishof; Mihaela Lucia Popa et al. (2013). Histone deacetylase inhibisjon i kombinasjon med platinum i en klinisk relevant ortotopisk musemodel for ovarialcancer. (ekstern lenke)
• Øystein Helland; Mihaela Lucia Popa; Bjørn Tore Gjertsen et al. (2013). Panobinostat / carboplatin delay postsurgical relapse of ovarian carcinomas in an orthotopic mouse model. (ekstern lenke)
• Zahra Pervaiz; Lobke Gierman; Gabriela Silva et al. (2016). Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Nina McCarthy; Philip E. Melton et al. (2014). A genetic connection between preeclampsia and chronic hypertension in Norwegian families. (ekstern lenke)
• Christiane Helgestad Gjerde; Anika Langer; Gorka Ruiz de Garibay et al. (2021). Establishment of ovarian cancer organoids on peritoneal dECM scaffolds. (ekstern lenke)
• Lobke Gierman; Gabriela Silva; Zahra Pervaiz et al. (2019). Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia. (ekstern lenke)
• Lobke Gierman; Gabriela Silva; Zahra Pervaiz et al. (2019). Toll-Like Receptor-3 expression by maternal and fetal cells at the maternal-fetal interface is associated with development of preeclampsia. (ekstern lenke)
• Gabriela Silva; Guro Stødle; Lobke Gierman et al. (2018). Inflammation at the uterine wall lining in pregnancy.. (ekstern lenke)
• Zahra Pervaiz; Lobke Gierman; Gabriela Silva et al. (2018). TLR3 expression and activation at the maternal-fetal interface in pregnancy. (ekstern lenke)
• Ingrid Alsos Lian; Mari Løset; Siv Boon Mundal et al. (2011). Endoplasmic reticulum stress in decidual tissue from pregnancies complicated by pre-eclampsia and fetal growth restriction. (ekstern lenke)
• Lobke Gierman; Guro Stødle; Gabriela Silva et al. (2016). NLRP3 inflammasome expression and activation at the maternal-fetal interface in preeclamptic and healthy pregnancies. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Philip E. Melton; Kjersti Tollaksen et al. (2014). Heritability of cardiovascular diseases in a preeclampsia family cohort. (ekstern lenke)
• Karen Rosnes Gissum; Sigrunn Drageset; Liv Cecilie Vestrheim Thomsen et al. (2022). Quality of Life of Patients with Ovarian Cancer: Biological Perspective Versus Patient Perspective. (ekstern lenke)
• Katrin Kleinmanns; Vibeke Samuelsen Fosse; Ben Davidson et al. (2019). EP889 improved cytoreduction of ovarian cancer using CD24 targeted fluorescence image guided surgery in a preclinical murine model. (ekstern lenke)
• Karen Rosnes Gissum; Sigrunn Drageset; Ingvild Vistad et al. (2019). What you should know about tumor reductive surgery in advanced ovarian cancer – Clinical recommendations from a patient perspective. (ekstern lenke)
• Marie Austdal; Gabriela Brettas Silva; Sophie Bowe et al. (2019). Metabolomics identifies placental dysfunction and confirms Flt-1 biomarker specificity.. (ekstern lenke)
• Linda Tømmerdal Roten; LCV Thomsen; Astrid Gundersen et al. (2011). Establishment of a Norwegian Preeclampsia Family Biobank. (ekstern lenke)
• Anders Hagen Jarmund; Johanne Johnsen Rakner; Åse Turid Rossevatn Svoren et al. (2025). sFlt-1 at the maternal-fetal interface and in maternal serum is not coregulated and show divergent upregulation in preeclampsia subtypes. (ekstern lenke)
• Karen Rosnes Gissum; Sigrunn Drageset; Liv Cecilie Vestrheim Thomsen et al. (2022). Living with Ovarian Cancer: Transitions Lost in Translation. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Philip E. Melton; Kjersti Tollaksen et al. (2013). Heritability of cardiovascular diseases in a preeclampsia family cohort. (ekstern lenke)
• Astrid Gundersen; Liv Cecilie Vestrheim; Irina Poliakova Eide et al. (2010). Biobanking of tissue and blood from pregnancies. (ekstern lenke)
• Marie Austdal; Liv Cecilie Vestrheim Thomsen; Line Tangerås et al. (2015). Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics. (ekstern lenke)
• Liv Cecilie Vestrheim Thomsen; Linda Tømmerdal Roten; Ann-Charlotte Iversen et al. (2012). A family based cohort study design to investigate genetic predisposition to preeclampsia and cardiovascular disease. The Norwegian Preeclampsia Family Study. (ekstern lenke)
• Katrin Kleinmanns; Shamundeeswari Anandan; Ida Tveit Karlsen et al. (2017). Engraftement optimization, charaterization and tumor spread tracking by preclinical imaging in ovarian cancer patiant. (ekstern lenke)
• Christiane Helgestad Gjerde; Anika Langer; Gorka Ruiz de Garibay et al. (2022). Establishment of peritoneal dECM scaffolds for 3D culture of ovarian cancer organoids. (ekstern lenke)
• Linda Grung Ertzeid; Ingrid Økland; Line Bjørge et al. (2010). Medical abortion between 9 and 12 weeks gestation. Experiences from a nursing perspective.. (ekstern lenke)
• Guro Stødle; Gabriela Silva; Line Haugstad Tangerås et al. (2015). The NLRP3 inflammasome in placentas from preeclamptic and healthy pregnancies. (ekstern lenke)
• Line Haugstad Tangerås; Lobke Gierman; Guro Stødle et al. (2015). The inflammatory role of HMGB1 in preeclamptic and normal pregnancies. (ekstern lenke)
• Liv Cecilie Vestrheim; Rigmor Austgulen; Kari Klungsøyr Melve et al. (2010). Classification of pre-eclamptic pregnancies in health registries. An evaluation of criteria selected and pregnancies included in the Medical Birth Registry of Norway. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Lobke Gierman; Gabriela Silva; Zahra Pervaiz et al. (2020). TLR3 expression by maternal and fetal cells at the maternal-fetal interface in normal and preeclamptic pregnancies. (ekstern lenke)
• Antoinette Hollestelle; Frederieke H Van Der Baan; Andrew Berchuck et al. (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (ekstern lenke)
• Kremena Petrova Trichkova; Franziska Stilla Maria Görtler; Line Bjørge et al. (2024). Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors. (ekstern lenke)
• Ferenc Macsali; Cecilie Svanes; Line Bjørge et al. (2012). Respiratory health in women: from menarche to menopause. (ekstern lenke)
• Martin Widschwendter; Allison Jones; Iona Evans et al. (2018). Epigenome-based cancer risk prediction: Rationale, opportunities and challenges. (ekstern lenke)
• Katrin Kleinmanns; Vibeke Samuelsen Fosse; Line Bjørge et al. (2020). The emerging role of cd24 in cancer theranostics—a novel target for fluorescence image-guided surgery in ovarian cancer and beyond. (ekstern lenke)
• Andrea Svennevik Myhr; Line Bjørge; Cecilie Fredvik Torkildsen (2024). Secondary Cytoreductive Surgery in Relapsed Platinum-Sensitive Epithelial Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. (ekstern lenke)

Forelesning

• Gabriela Brettas Silva; Lobke Gierman; Guro Stødle et al. (2019). The NLRP3 inflammasome expression by maternal and fetal cells in the uterine wall and association with preeclampsia development.. (ekstern lenke)
• Linn Okkenhaug Getz; Caroline Benedicte Nitter Engen; Line Bjørge et al. (2023). Responsible clinical trials i the age of personalized medicine. (ekstern lenke)
• Signe Haaland Buer; Anders Hagen Jarmund; Åse Turid Rossevatn Svoren et al. (2023). Distinct immunological development throughout pregnancies complicated with preeclampsia, gestational hypertension, and chronic hypertension. (ekstern lenke)
• Guro Stødle; Gabriela Silva; Line Haugstad Tangerås et al. (2017). Inflammation in preeclampsia by NOD-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. (ekstern lenke)
• Johanne Johnsen Rakner; Lobke Gierman; Gabriela Silva et al. (2017). An inflammatory role for NOD1 in decidua and placenta of normal and preeclamptic pregnancies. (ekstern lenke)
• Siv Boon Mundal; Gabriela Brettas Silva; Lobke Gierman et al. (2019). Divergent regulation of decidual oxidative stress response in preeclampsia with and without fetal growth restriction. (ekstern lenke)
• Line Tangerås; Guro Stødle; Liv Cecilie Vestrheim Thomsen et al. (2014). Inflammation in normal and preeclamptic pregnancies. (ekstern lenke)
• Gabriela Brettas Silva; Lobke Gierman; Guro Stødle et al. (2019). NLRP3 inflammasome expression by maternal and fetal cells in decidua and its association with preeclampsia. (ekstern lenke)

Vitenskapelig bokkapittel

• Einar Klæboe Kristoffersen; Line Bjørge (2007). Immunologi og reproduksjon. (ekstern lenke)

Leserbrev

• Kjetil Tasken; Hege Elisabeth Giercksky Russnes; Eline Aas et al. (2022). A national precision cancer medicine implementation initiative for Norway. (ekstern lenke)

Kapittel i fagbok

• Mihaela-Lucia Popa; Vibeke Samuelsen Fosse; Katrin Kleinmanns et al. (2021). Xenograft Models of Ovarian Cancer for Therapy Evaluation. (ekstern lenke)

Doktorgradsavhandling

• Daniela Elena Costea; Line Bjørge; Anne Christine Johannessen et al. (2020). Biomarkers and preclinical models for more precise diagnosis and personalized treatment of oral and vulva carcinomas - Study on human samples and experimental models. (ekstern lenke)
• Katharina Bischof; Line Bjørge; Bjørn Tore Gjertsen et al. (2019). Rethinking Gynecological High- Grade Serous Carcinoma. Portraying the p53 isoform landscape and development of a new preclinical for optical imaging in xenograft models. (ekstern lenke)
• Line Bjørge (1996). Complement regulatory proteins in malignancies. (ekstern lenke)

Fremhevet artikkel i media

• Mari Nygård; Emily Annika Burger; Ståle Nygård et al. (2023). Skal vi screene og konisere inn i evigheten – eller bytte HPV-vaksine?. (ekstern lenke)

Populærvitenskapelig artikkel

• Matthew A. Powell; Line Bjørge; Lyndsay Willmott et al. (2025). A plain language summary publication of patients’ survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel. (ekstern lenke)

Lederartikkel

• Ingvild Vistad; Line Bjørge (2023). Advanced endometrial cancer: New medical treatment options on the horizon. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.